Fig. 4From: Efficacy and safety of artemisinin-based combination therapies for the treatment of uncomplicated malaria in pediatrics: a systematic review and meta-analysisMeta-analysis of safety of artemisinin combination therapy administration (PR: DerSimonian-larid random-effects untransformed proportion). Abbreviations: - C.I.: confidence interval, n: events, N: total in the intention-to-treat analysis, CDA: Chlorproguanil-dapsone-artesunate, AL: Artemether–Lumefantrine, DP: dihydroartemisinin-piperaquine, ASAQ: Artesunate–Amodiaquine, PA: pyronaridine-artesunate, ASSMP: Artesunate-Sulphamethoxypyrazine-PyrimethamineBack to article page